takotsubo cardiomyopathy
Recently Published Documents


TOTAL DOCUMENTS

2717
(FIVE YEARS 707)

H-INDEX

53
(FIVE YEARS 6)

Cureus ◽  
2022 ◽  
Author(s):  
Amit Ramrattan ◽  
Iovank Gonzalez ◽  
Harun Abdullah ◽  
Kevin Maraj ◽  
Mariana Browne

CJEM ◽  
2022 ◽  
Author(s):  
Francis Desmeules ◽  
Stéphane Côté

Cureus ◽  
2022 ◽  
Author(s):  
Abdullah Jahangir ◽  
Muhammad Rafay Khan Niazi ◽  
Syeda Sahra ◽  
Aneeqa Javed ◽  
Michael Krzyzak

Author(s):  
Tatsuhiko Azegami ◽  
Akinori Hashiguchi ◽  
Takashin Nakayama ◽  
Kaori Hayashi ◽  
Takeshi Kanda ◽  
...  

Author(s):  
Ageliki Laina ◽  
Georgios Latsios ◽  
Eirini Dri ◽  
Constantina Aggeli ◽  
Eleftherios Tsiamis ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Mizuki Kimura ◽  
Shunta Hashiguchi ◽  
Kenichi Tanaka ◽  
Manato Hagiwara ◽  
Keita Takahashi ◽  
...  

Takotsubo cardiomyopathy (TCM) is a stress-induced cardiomyopathy triggered by critical illness including severe neurological disorders. However, an association between TCM and Bickerstaff brainstem encephalitis (BBE) has rarely been described. During the current coronavirus disease 2019 (COVID-19) pandemic, growing evidence indicates that COVID-19 often leads to various neurological disorders, but there are few reports of an association between COVID-19 and BBE. Here we report a case of TCM associated with BBE triggered by COVID-19, which subsided with immunotherapy for BBE. Both transthoracic echocardiography and electrocardiography led to early and accurate diagnosis of TCM. Sustained hemodynamic instability due to TCM was immediately lessened with immunotherapy whereas additional plasmapheresis and immunotherapy were required to treat BBE. This case indicates that BBE might follow COVID-19 and TCM should be considered when hemodynamic status remains unstable in a patient with BBE.


Sign in / Sign up

Export Citation Format

Share Document